AIM
ENZ

Alambic Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Alambic Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-41,097
Closed -$114K – 402
2018
Q4 		$114K Sell
41,097
-53,162
-56% -$174K 0.05% 273
2018
Q3 		$388K Sell
94,259
-13,978
-13% -$63.5K 0.31% 118
2018
Q2 		$562K Sell
108,237
-21,899
-17% -$133K 0.15% 197
2018
Q1 		$713K Buy
+130,136
New +$917K 0.1% 276

Other funds holding ENZ

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alambic Investment Management's ENZ Position: Q1 2019 in Review

Alambic Investment Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2019, closing a stake of 41,097 shares — an estimated $114K sold.

Alambic Investment Management first reported a position in ENZ in Q1 2018 and held it in 4 quarters. The position peaked at $713K in Q1 2018. 85 funds tracked by Wall St. Rank hold ENZ as of Q1 2019.

  • Alambic Investment Management reported no remaining Enzo Biochem, Inc. position as of Q1 2019 after selling out during the quarter.
  • Alambic Investment Management sold 41,097 Enzo Biochem, Inc. shares in Q1 2019, an estimated $114K.
  • Alambic Investment Management first reported a position in Enzo Biochem, Inc. in Q1 2018 and held it in 4 quarters.
  • Alambic Investment Management's Enzo Biochem, Inc. position peaked at $713K in Q1 2018.
  • 85 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2019.

Based on Alambic Investment Management's 13F filing for Q1 2019, filed 9 May 2019.